Mera Pharmaceuticals, Inc. (MRPI)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 12, 16:00
Mera Pharmaceuticals Net Income (TTM)
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| October 31, 2011 | -0.1877M |
| July 31, 2011 | -0.48M |
| April 30, 2011 | -0.5124M |
| January 31, 2011 | -0.5551M |
| October 31, 2010 | -0.5378M |
| July 31, 2010 | -0.2437M |
| April 30, 2010 | -0.2868M |
| January 31, 2010 | -0.1861M |
| October 31, 2009 | -0.1929M |
| July 31, 2009 | -1.857M |
| April 30, 2009 | -1.758M |
| January 31, 2009 | -1.854M |
| October 31, 2008 | -1.945M |
| July 31, 2008 | -0.1966M |
| April 30, 2008 | -0.288M |
| January 31, 2008 | -0.2791M |
| October 31, 2007 | -0.3223M |
| July 31, 2007 | -0.4168M |
| April 30, 2007 | -0.4566M |
| January 31, 2007 | -0.5535M |
| October 31, 2006 | -0.5084M |
| July 31, 2006 | -0.9909M |
| April 30, 2006 | -1.097M |
| January 31, 2006 | -1.171M |
| October 31, 2005 | -1.304M |
| Date | Value |
|---|---|
| July 31, 2005 | -0.7488M |
| April 30, 2005 | -1.491M |
| January 31, 2005 | -1.163M |
| October 31, 2004 | -1.104M |
| July 31, 2004 | -1.679M |
| April 30, 2004 | -0.8622M |
| January 31, 2004 | -1.391M |
| October 31, 2003 | -1.831M |
| July 31, 2003 | -2.216M |
| April 30, 2003 | -2.483M |
| January 31, 2003 | -2.545M |
| October 31, 2002 | -2.39M |
| July 31, 2002 | -2.602M |
| April 30, 2002 | -3.012M |
| January 31, 2002 | -3.337M |
| October 31, 2001 | -4.092M |
| July 31, 2001 | |
| April 30, 2001 | |
| January 31, 2001 | |
| October 31, 2000 | |
| July 31, 2000 | |
| April 30, 2000 | |
| January 31, 2000 | |
| October 31, 1999 | |
| July 31, 1999 | -3.457M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Sarepta Therapeutics, Inc. | -266.10M |
| Anixa Biosciences, Inc. | -10.47M |